BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imam F, Al-Harbi NO, Al-Harbi MM, Qamar W, Aljerian K, Belali OM, Alsanea S, Alanazi AZ, Alhazzani K. Apremilast ameliorates carfilzomib-induced pulmonary inflammation and vascular injuries. Int Immunopharmacol 2019;66:260-6. [PMID: 30500623 DOI: 10.1016/j.intimp.2018.11.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Mugheddu C, Pizzatti L, Sanna S, Atzori L, Rongioletti F. COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management. J Eur Acad Dermatol Venereol 2020;34:e376-8. [PMID: 32385859 DOI: 10.1111/jdv.16625] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
2 Shawki MA, Elsayed NS, Mantawy EM, Said RS. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications. Immunopharmacol Immunotoxicol 2021;43:395-409. [PMID: 34057871 DOI: 10.1080/08923973.2021.1931302] [Reference Citation Analysis]
3 Al-harbi NO, Imam F, Matar Al-harbi M, Al-jeryan K, Al-shabanah OA, Alhosaini KA, Saif Alqahtani L, Afzal M, Khalid Anwer M, Aldossari AA, Alanazi MM, Alsanea S, Assiri MA. Protective effect of Apremilast against LPS-induced acute lung injury via modulation of oxidative stress and inflammation: Possible involvement of Akt and ERK signaling pathways. Saudi Journal of Biological Sciences 2022. [DOI: 10.1016/j.sjbs.2022.02.023] [Reference Citation Analysis]
4 Wu Y, Sreeharsha N, Sharma S, Mishra A, Singh AK, Gubbiyappa SK. Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis. ACS Omega 2020;5:5334-9. [PMID: 32201822 DOI: 10.1021/acsomega.9b04357] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Santaniello A, Vigone B, Beretta L. Letter to the editor: Immunomodulation by phosphodiesterase-4 inhibitor in COVID-19 patients. Metabolism 2020;110:154300. [PMID: 32574572 DOI: 10.1016/j.metabol.2020.154300] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jia Y, Chen X, Sun J. Apremilast ameliorates IL-1α-induced dysfunction in epidermal stem cells. Aging (Albany NY) 2021;13:19293-305. [PMID: 34375302 DOI: 10.18632/aging.203265] [Reference Citation Analysis]
7 Yin H, Qin H, Wang T, Zhuang Q, Yang Q. The Protective Effects of Apremilast Against Oxygen-Glucose Deprivation/Reperfusion (OGD/R)-Induced Inflammation and Apoptosis in Astroglia Mediated by CREB/BDNF. Neurotox Res 2021;39:754-63. [PMID: 33826130 DOI: 10.1007/s12640-021-00340-2] [Reference Citation Analysis]
8 Lin FC, Lee SS, Li YC, Ho YC, Chen WY, Chen CJ, Lee MW, Yeh KL, Tsai SC, Kuan YH. Protective Effects of Kirenol against Lipopolysaccharide-Induced Acute Lung Injury through the Modulation of the Proinflammatory NFκB Pathway and the AMPK2-/Nrf2-Mediated HO-1/AOE Pathway. Antioxidants (Basel) 2021;10:204. [PMID: 33572510 DOI: 10.3390/antiox10020204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]